CBIO 8-K 2026-07-15

CRESCENT BIOPHARMA, INC. (CBIO) 8-K dated 2026-07-15 — accession 0001628280-26-048347. This URL is the filing, not the CBIO hub.

CRESCENT BIOPHARMA, INC. (CBIO) is a biotechnology company listed on NASDAQ.

CRESCENT BIOPHARMA, INC. filed a 8-K on 2026-07-15. Accession 0001628280-26-048347.

Cached items: 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported CBIO revenue for 2026-06-30 was $1.0M. Net income was -$48.1M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. CBIO currently screens at market cap $491.3M.

Not investment advice. The CBIO SEC hub lists recent forms. The stock page is the research view.